Patent Extensions’ Cost To Be Evaluated By FDA Under Ag Approps Request
Executive Summary
FDA will report on the costs to consumers of drug patent extensions by March
You may also be interested in...
FDA Generic Drug Promotional Campaign Features Newspaper Articles
FDA's educational campaign to encourage the use of generic drugs will be launched in late July with an informational article appearing in local newspapers nationwide
FDA Generic Drug Promotional Campaign Features Newspaper Articles
FDA's educational campaign to encourage the use of generic drugs will be launched in late July with an informational article appearing in local newspapers nationwide
FDA Patent Listing Procedures May Need Revision, Hatch And Waxman Say
FDA should apply more judgment in analyzing patents submitted for listing in the "Orange Book" when generic competition is imminent, Sens. Kennedy (D-Mass.) and Hatch (R-Utah) and Rep. Waxman (D-Calif.) said in a letter to HHS Secretary Thompson.